Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGynecological OncologyDiseaseChorionic CarcinomaGestational Trophoblastic NeoplasiaSubgroupICD10C58D39.-D39.2MeSHChoriocarcinomaGestational Trophoblastic DiseaseSequenceChemotherapyChemo-substanceDactinomycinChemo-substanceDactinomycinChemo-substanceDactinomycinChemo-substanceDactinomycinNo. Substances1 RadiotherapySupportive therapySupportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Supportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Supportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Supportive substanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%No. Substances4Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseInductionTherapy intentioncurativeRisksAnemia Hb below 8g/dlAnemia Hb below 10g/dlEmetogenicity (MASCC/ESMO)HemorrhageInfectionsNeutropeniaThrombocytopenia below 50 000/µl only studiesPublicationAuthorOsborne RJDiseaseTrophoblastäre gestationale Neoplasie und nichtmetastasiertes ChorionkarzinomOriginThe Gynecologic Oncology GroupProtocols in Revision 1 protocol foundProtocols under revision.Dactinomycin 1,25, Gestational Trophoblastic Neoplasia (PID95 V1.0)
